Quarterly ResultMay 7, 2026, 04:15 PM
GENELUX Q1 Net Loss $8.9M; Raises $18.5M from Stock Offering
AI Summary
GENELUX Corp reported a net loss of $8.9 million for the three months ended March 31, 2026, an increase from $7.5 million in the prior year, with operating expenses rising to $9.2 million. The company's independent auditors expressed substantial doubt about its ability to continue as a going concern. However, GENELUX strengthened its financial position by raising $18.5 million through a common stock offering in January 2026, extending its liquidity runway into the first quarter of 2027.
Key Highlights
- Net loss for Q1 2026 was $8.9 million, compared to $7.5 million in Q1 2025.
- Operating expenses increased to $9.2 million in Q1 2026 from $7.8 million in Q1 2025.
- Research and development expenses rose to $5.8 million in Q1 2026 from $4.7 million in Q1 2025.
- GENELUX raised $18.5 million in net proceeds from a common stock offering in January 2026.
- Cash, cash equivalents, and restricted cash totaled $9.3 million as of March 31, 2026.
- Marketable securities increased to $16.9 million as of March 31, 2026.
- Existing capital is expected to fund operations into the first quarter of 2027.
- Lease terms for San Diego facilities were extended to October 31, 2035.